Arcadia Biosciences, Inc. (RKDA): R&D Expense
$9.0K
Year ended 2025-12-31
$0
Trailing 12 months to 2026-06-30
-81.9%
3-year compound annual growth
-74.3%
5-year compound annual growth
-49.9%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.0K | -83.0% | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | $53.0K | -17.2% | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | $64.0K | -95.8% | 2025-03-25, From 2023-01-01 |
| 2022-12-31 | $1.51M | -61.2% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $3.89M | -51.1% | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | $7.96M | +12.1% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $7.10M | +17.0% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $6.07M | -18.1% | 2020-03-25, From 2018-01-01 |
| 2017-12-31 | $7.41M | -14.5% | 2019-04-01, From 2017-01-01 |
| 2016-12-31 | $8.66M | -3.4% | 2018-03-20, From 2016-01-01 |
| 2015-12-31 | $8.97M | -10.4% | 2017-03-08, From 2015-01-01 |
| 2014-12-31 | $10.01M | n/a | 2016-03-08, From 2014-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| Arcadia Biosciences, Inc. (RKDA) | 2025-12-31 | $9.0K | -83.0% |
| Abundia Global Impact Group, Inc. (AGIG) | 2025-12-31 | $752.3K | -54.4% |
| Prairie Operating Co. (PROP) | 2025-12-31 | $152.90M | +302.4% |
| Tamboran Resources Corp (TBN) | 2025-06-30 | $6.04M | n/a |
Compare RKDA, AGIG, PROP, TBN side by side · Screen every company in Crude Petroleum & Natural Gas ↗